Answer
Trastuzumab may remain in the circulation for up to seven months after stopping Herceptin treatment, based on population pharmacokinetic analysis of all available data.
Sources for this answer
- Herceptin 150mg Powder for concentrate for solution for infusionRoche Products Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 52Document updated
Sources checked